A 'cadherin switch' with increased N-cadherin and reduced E-cadherin expression has been associated with relapse after PCa surgery and development of metastatic disease (Gravdal et al., 2007; Umbas et al., 1992). Here, CDH17 is linked to metastatic neoplasm.